Cerespectus is developing a minimally invasive, catheter-based platform that enables real-time, image-guided catheter placement and infusion into the cerebrospinal fluid via lumbar access. It is a safer and more accessible alternative to traditional methods to treat neurological diseases. Our innovation bridges the gap between groundbreaking gene therapies and effective delivery, transforming patient outcomes while increasing treatment effectiveness, reducing costs, and improving healthcare equity.